NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/02/2024
Back to search
Official data from USPTO
ACROTECH BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACROTECH BIOPHARMA
ST13
US500000090608961Class
40, 42
Filing
90608961
Registration
7262657
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
01/02/2024
Trademark type
Word
Nice classes
40, 42
Filing date
03/29/2021
Registration date
01/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/02/2024
Last transaction
01/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/02/2019
First use in commerce
12/02/2019
Drawing code
4
Owner type
03
Owner location
EAST WINDSOR, NJ
Examiner
ENGEL, MICHAEL
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ACROTECH BIOPHARMA INC.
Acrotech Biopharma LLC
Acrotech Biopharma, LLC
Representatives
Sandra J Wunderlich Tucker Ellis LLP
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Manufacturing of pharmaceuticals for others
Class 42
Development of pharmaceutical preparations and medicines
Publications
History of USPTO decisions and trademark events.
42 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/02/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/29/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/28/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/17/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/17/2023
IUAF
USE AMENDMENT FILED
11/03/2023
EISU
TEAS STATEMENT OF USE RECEIVED
11/03/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/11/2023
EX2G
SOU EXTENSION 2 GRANTED
05/09/2023
EXT2
SOU EXTENSION 2 FILED
05/09/2023
EEXT
SOU TEAS EXTENSION RECEIVED
05/09/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/01/2022
EX1G
SOU EXTENSION 1 GRANTED
09/29/2022
EXT1
SOU EXTENSION 1 FILED
09/29/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/29/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/14/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/07/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/07/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/10/2022
CHPB
POST PUBLICATION AMENDMENT - ENTERED
03/15/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/15/2022
PUBO
PUBLISHED FOR OPPOSITION
03/15/2022
APET
ASSIGNED TO PETITION STAFF
03/14/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
03/03/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/23/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/08/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/04/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/04/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/04/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/09/2021
GNRT
NON-FINAL ACTION E-MAILED
11/09/2021
CNRT
NON-FINAL ACTION WRITTEN
11/09/2021
DOCK
ASSIGNED TO EXAMINER
11/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/04/2021
NWAP
NEW APPLICATION ENTERED
04/01/2021
Continuous trademark protection
Get notified about every new filing that threatens ACROTECH BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.